We hypothesized that bone marrow-derived mononuclear cell (BMDMC) therapy protects the lung and consequently the heart in experimental elastase-induced emphysema. Twenty-four female C57BL/6 mice were intratracheally instilled with saline (C group) or porcine pancreatic elastase (E group) once a week during 4 weeks. C and E groups were randomized into subgroups receiving saline (SAL) or male BMDMCs (2 × 10 6 , CELL) intravenously 3 h after the first saline or elastase instillation. Compared to E-SAL group, E-CELL mice showed, at 5 weeks: lower mean linear intercept, neutrophil infiltration, elastolysis, collagen fiber deposition in alveolar septa and pulmonary vessel wall, lung cell apoptosis, right ventricle wall thickness and area, higher endothelial growth factor and insulin-like growth factor mRNA expressions in lung tissue, and reduced platelet-derived growth factor, transforming growth factor-␤, and caspase-3 expressions. In conclusion, BMDMC therapy was effective at modulating the inflammatory and remodeling processes in the present model of elastase-induced emphysema.
Introduction
Chronic obstructive pulmonary disease (COPD), comprised of emphysema and chronic bronchitis, is the fourth leading cause of death in the United States and thus a major public health concern (Mannino and Braman, 2007) . Emphysema, defined as irreversible destruction of the alveoli, is associated with inflammation in the airways and lung parenchyma (Snider, 1985) . In addition to the well-known impact of emphysema on the lungs, extrapulmonary systemic effects have also been described (Agusti et al., 2003) . In this line, pulmonary hypertension, which results from destruction of the capillary network embedded in the alveolar walls, may lead to cor pulmonale, an alteration of the structure and function of the right ventricle that significantly contributes to the severity and mortality of emphysema (Fabbri et al., 2006 (Fabbri et al., , 2008 . Although substantial progress has been made in understanding many of the molecular mechanisms underlying emphysema (Brusselle et al., 2011; Churg et al., 2011) , this knowledge has not translated into effective therapies (Sutherland and Cherniack, 2004; Barnes and Stockley, 2005; Rabe and Wedzicha, 2011) . To date, antioxidant and anti-inflammatory therapies yield only limited improvement in lung function (Rabe and Wedzicha, 2011) .
Adult bone marrow-derived stem cells are potent modulators of immune responses, promoting cell proliferation and re-epithelization of the injured lung (Yamada et al., 2004; Rojas et al., 2005; Xu et al., 2007; Gupta et al., 2007; Abreu et al., 2011a) . Based on this assumption, several studies have shown beneficial effects of cell-based therapy in experimental emphysema induced by cigarette smoke (Huh et al., 2011; Schweitzer et al., 2011) , papain (Zhen et al., 2008 (Zhen et al., , 2010 , as well as elastase (Shigemura et al., 2006; Katsha et al., 2011) . These effects have been attributed to immunomodulation either from cytokine release or activation of the endogenous immune system (Rojas et al., 2005; Rasmusson, 2006; Ortiz et al., 2007) , since low level of bone marrow cell retention has been observed. Nevertheless, so far, no report has described the impact of cell-based therapy not only on lung, but also on heart in emphysema.
Therefore, the aim of this study was to test the hypothesis that bone marrow-derived mononuclear cell (BMDMC) therapy doi:10.1016/j.resp.2012.01.002 may act on inflammatory and remodeling processes, reducing lung damage and thus improving cardiac function in a murine model of pulmonary elastase-induced emphysema. For this purpose, we analyzed lung histology, elastic and collagen fiber content in the alveolar septa and pulmonary vessel wall, the expression of growth factors in lung tissue, and echocardiographic parameters.
Material and methods
This study was approved by the Ethics Committee of the Carlos Chagas Filho Institute of Biophysics, Health Sciences Center, Federal University of Rio de Janeiro (Number of study approval: IBCCF019). All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences, USA.
Extraction and characterization of bone marrow-derived mononuclear cells
Bone marrow cells from 5 male C57BL/6 mice were flushed from the femurs and tibias with Dulbecco's modified Eagle's medium (DMEM). After a homogeneous cell suspension was achieved, cells were centrifuged (400 × g for 10 min), resuspended in DMEM and added to Ficoll-Hypaque. The isolated cells were counted in a Neubauer chamber with Trypan Blue for evaluation of viability. Saline or BMDMC were slowly injected into the jugular vein. A small aliquot of mononuclear cells was used for immunophenotypic characterization of the injected cell population. Cell characterization was performed by flow cytometry using antibodies CD45 (leukocyte), CD34 (hematopoietic precursors), CD3, CD8, and CD4 (T lymphocyte), CD14 (monocytes and macrophages), CD11b, CD29 and CD45-(non-hematopoietic precursors), all from BD Biosciences, USA (Abreu et al., 2011a) .
Animal preparation and experimental protocol
Twenty-four female and five male C57BL/6 mice (20-25 g) were used in this study. The animals were kept under specific pathogen-free conditions in the animal care facility of Laboratory of Pulmonary Investigation, Federal University of Rio de Janeiro.
Females were randomly assigned into control (C) and elastaseinduced emphysema (E) groups. In C group, sterile saline solution (0.9% NaCl) was intratracheally (i.t.) instilled (50 l), while in E group, mice received porcine pancreatic elastase i.t. (0.1 UI, 50 l of saline solution, PPE -Sigma Chemical Co., St. Louis, MO, USA). Saline and PPE were administered once a week during 4 weeks. For intratracheal instillation, mice were anesthetized with sevoflurane. A midline cervical incision (1 cm) was made to expose the trachea, and saline or PPE were instilled using a bent 27-gauge tuberculin needle. The cervical incision was closed with 5.0 silk suture and the mice returned to their cage.
Three hours after the first instillation of saline or PPE, animals were further randomized into subgroups receiving saline solution (0.9% NaCl, 50 l, SAL) or BMDMC (2 × 10 6 cells diluted in 50 l saline solution, CELL) through the left jugular vein (Fig. 1) .
Echocardiography
For acquisition of the images, VEVO 770 form Visual Sonics (Canada) coupled to a 30 MHz transducer was used. Images were obtained from the subcostal and parasternal views. M-mode images showed right ventricular muscle thickness. Short and long-axis Bdimensional views of both ventricles were acquired at the level of the papillary muscles to obtain left and right ventricular areas, as well as left ventricular cardiac output and ejection fraction by Simpson's method (Lang et al., 2006) . All parameters followed the recommendations of the American and European Societies of echocardiography.
Lung histology
One week after the last intratracheal instillation of saline or PPE, animals were sedated (diazepam 1 mg ip), anesthetized (thiopental sodium 20 mg/kg ip), tracheotomized, paralyzed (vecuronium bromide, 0.005 mg kg iv), and ventilated with a constant flow ventilator (Samay VR15; Universidad de la Republica, Montevideo, Uruguay) with the following parameters: frequency of 100 breaths/min, tidal volume (V T ) of 0.2 ml, and fraction of inspired oxygen of 0.21. The anterior chest wall was surgically removed and a positive endexpiratory pressure of 2 cm H 2 O applied.
A laparotomy was performed and heparin (1000 IU) was intravenously injected in the vena cava. The trachea was clamped at end-expiration, and the abdominal aorta and vena cava were sectioned, yielding a massive hemorrhage that quickly killed the animals. The right lung was then removed, fixed in 3% buffered formaldehyde and paraffin embedded. Four-m-thick slices were cut and stained with hematoxylin-eosin. Lung morphometry analysis was performed with an integrating eyepiece with a coherent system consisting of a grid with 100 points and 50 lines (known length) coupled to a conventional light microscope (Olympus BX51, Olympus Latin America-Inc., Brazil). The volume fractions of the lung occupied by collapsed alveoli (alveoli with rough or plicate walls), normal pulmonary areas or hyperinflated structures (alveolar ducts, alveolar sacs, or alveoli, all with maximal chord length in air >120 m) were determined by the point-counting technique (Weibel, 1990) across 10 random, non-coincident microscopic fields. Briefly, points falling on collapsed, normal pulmonary areas or hyperinflated structures were counted and divided by the total number of points in each microscopic field.
Enlargement of air spaces was evaluated using mean linear intercept measurement (Lm) (Dunnill, 1964) . The fraction of neutrophils and mononuclear cells was also evaluated. Collagen (Picrosirius-polarization method) and elastic fibers (Weigert's resorcin fuchsin method with oxidation) (Fullmer et al., 1974) were quantified in alveolar septa and pulmonary vessel wall.
Transmission electron microscopy
Three slices of 2 mm × 2 mm × 2 mm were cut from three different segments of the left lung and fixed [2.5% glutaraldehyde and phosphate buffer 0.1 M (pH = 7.4)] for electron microscopy (JEOL 1010 Transmission Electron Microscope, Tokyo, Japan) analysis. For each lung electron microscopy image (20/animal), the following alterations were analyzed: (a) alveolar-capillary membrane damage, (b) type II pneumocyte lesion, (c) endothelial cell lesion, (d) neutrophil infiltration, (e) elastic fiber breakdown, (f) collagen fiber deposition, and (g) apoptotic cells (Abreu et al., 2011a) . The pathologic findings were graded according to a 5-point semi-quantitative severity-based scoring system as: 0 = normal lung parenchyma, 1 = changes in 1-25%, 2 = changes in 26-50%, 3 = changes in 51-75%, and 4 = changes in 76-100% of examined tissue.
Apoptosis assay of lung
Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling staining was used to assay cellular apoptosis (Oliveira et al., 2009) . Ten fields per section from the regions with cell apoptosis were examined at a magnification of ×400. A 5-point semiquantitative severity-based scoring system was used to assess the degree of apoptosis: 0 = normal lung parenchyma; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; and 4 = 76-100% of examined tissue.
Y Chromosome DNA detection
Quantification of murine Y chromosome in lung tissue was achieved by quantitative real-time polymerase chain reaction (PCR). Briefly, DNA was purified in a 600 l solution of 0.2% sodium dodecyl sulfate (SDS)/proteinase K (300 g/ml), extracted with an equal volume of phenol/chloroform/isoamyl alcohol, and centrifuged for 15 min at 14,000 rpm. The aqueous phase was transferred to a new tube. DNA was precipitated with 2 volumes of ethanol 100% and centrifuged for 15 min at 14,000 rpm. DNA was resuspended and quantified in a nanodrop spectrophotometer. 5 ng of DNA was used in a real-time PCR reaction with SYBR Green detection kit run in 7000-sequence detection system thermocycler according to manufacturer instructions (Applied Biosystems, Foster City, CA). The following PCR primers were used: forward 5 -TCA TCG GAG GGC TAA AGT G-3 ; and reverse 5 -CAA CCT TCT GCA GTG GGA C-3 . Primers sequences were defined using primer3 software based on Mus musculus sex-determining region of Chr Y (Sry) gene, gene bank accession number: NM 011564 (National Institutes of Health, NIH, Bethesda, USA). These primers amplify an 88 bp product. The relative amount of total DNA was calculated as a ratio (2-Ct) of Sry and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Primers for GAPDH -Forward: 5 -CCA CCA ACT GCT TAG CCC-3 and reverse: 5 -GAC ACC TAC AAA GAA GGG TCC A-3 , 145 bp.
Expression of growth factors and caspase-3
In order to evaluate the mechanisms related to lung remodeling, quantitative real-time reverse transcription (RT) polymerase chain reaction (PCR) was performed to measure the expression of transforming growth factor (TGF)-␤, platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), insulinlike growth factor (IGF), and caspase-3 genes. Central slices of left lungs were cut, collected in cryotubes, quick-frozen by immersion in liquid nitrogen, and stored at −80 • C. Total RNA was extracted from the frozen tissues, using the Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. RNA concentration was measured by spectrophotometry in Nanodrop ® ND-1000. First-strand cDNA was synthesized from total RNA using M-MLV Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA). PCR primers for target gene were purchased (Invitrogen, Carlsbad, CA). The following primers were used: VEGF [5 -cca cga cag aag gag agc a-3 (forward) and 5 -aat cgg acg gca gta gct t-3 (reverse)], TGF-␤ [5 -ATA CGC CTG AGT GGC TGT C-3 (forward) and 5 -GCC CTG TAT TCC GTC TCC T-3 (reverse)], PDGF [5 -TCG AAG TCA GAT CCA CAG CA-3 (forward) and 5 -CTT GTC TCC AAG GCA TCC TC-3 (reverse)], IGF [5 -CTG GTG GAT GCT CTT CAG TTC-3 (forward) and 5 -CCA GTC TCC TCA GAT CAC AGC-3 (reverse)], and caspase-3 [5 -TAC CGG TGG AGG CTG ACT-3 (forward) and 5 -GCT GCA AAG GGA CTG GAT-3 (reverse)]. Relative mRNA levels were measured with a SYBR green detection system using ABI 7500 Real-Time PCR (Applied Biosystems, Foster City, CA). All samples were measured in triplicate. The expression of each gene was calculated as a ratio compared with the reference gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [5 -AAC TTT GGC ATT GTG GAA GG-3 (forward) and 5 -GTC TTC TGG GTG GCA GTG AT-3 (reverse)] and expressed as fold change relative to C-SAL.
Statistical analysis
Two-way ANOVA followed by Tukey's test was used to compare parametric data. For non-parametric data, two-way ANOVA on ranks followed by Dunn's post hoc test was selected. The significance level was always set at 5%. Parametric data were expressed as mean ± standard error mean (SEM), while non-parametric data were expressed as median (interquartile range). All tests were performed using SigmaStat 3.1 (Jandel Corporation, San Raphael, CA, USA).
Results
The pool of intravenously injected BMDMC was characterized by flow cytometry showing the following subpopulations: total lymphocytes (CD45+/CD11b−/CD29−/CD34− = 29.7%), T lymphocytes (CD45+/CD3+/CD34− = 5.4%), T helper lymphocytes (CD3+/CD4+/CD8− = 2.4%), T cytotoxic lymphocytes (CD3+/CD4−/ CD8+ = 2.3%), monocytes (CD45+/CD29+/CD11b−/CD34−/CD3− = 4.9%), neutrophils (CD45+/CD11b+/CD34−/CD29−/CD14−/ CD34−/CD3− = 50.1%), hematopoietic progenitors (CD34+/ CD45+ = 0.3%), and other progenitors cells (CD45− = 3.8%).
Echocardiography showed that E-SAL had greater right ventricular wall thickness and right ventricular area compared to C-SAL; BMDMC administration significantly reduced these parameters (Table 1, Fig. 2 ). There was no difference between any groups regarding left ventricular repercussions (area, cardiac output or ejection fraction).
Morphometric examination of lungs demonstrated that the mean linear intercept, the fraction area of alveolar collapse, hyperinflation, mononuclear cells and neutrophils in lung tissue, as well as collagen fiber content in alveolar septa and pulmonary vessel wall were higher in E-SAL than C-SAL group. Elastic fiber content was lower in E-SAL than C-SAL, and elastic fiber breakdown was more evident in E-SAL (Table 2, Fig. 3 ). BMDMC therapy minimized the fraction area of alveolar collapse, hyperinflation, and neutrophil infiltration, the amount of collagen fiber in the alveolar septa and pulmonary vessel wall (Table 2, Fig. 4) . It also prevented changes in the fraction area of mononuclear cells and elastic fiber content in the alveolar septa and pulmonary vessel wall. Values are mean ± SEM of 6 animals in each group. C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC (2 × 10 6 ) 3 h after the first instillation of saline or PPE. * Significantly different from C-SAL (p < 0.05). ** Significantly different from E-SAL (p < 0.05). Values are mean ± SEM of 6 animals in each group. All values were computed in ten random, non-coincident fields per mice. C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC (2 × 10 6 ) 3 h after the first instillation of saline or PPE. * Significantly different from C-SAL (p < 0.05). ** Significantly different from E-SAL (p < 0.05). Similarly, caspase-3 expression was lower in E-CELL compared to E-SAL (Fig. 5) .
Electron microscopy showed degeneration of the alveolar capillary membrane and damage to type II pneumocytes and endothelial cells, as well as increased neutrophil infiltration, elastic fiber breakdown and collagen fiber deposition in E-SAL group (Table 2, Fig. 6 ). In Fig. 6 (E-SAL) , epithelial and endothelial cells were not present.
BMDMC attenuated all these ultrastructural changes and yielded multinucleated cells and type II pneumocytes with large hyperplasia of lamellar bodies. Additionally, epithelial and endothelial cells were noted around the interstitium. Cell therapy also mitigated airway damage, reducing basement membrane irregularity and fragmentation, as well as disorganization and detachment of the airway epithelial cell layer (Table 3, Fig. 6 ).
Y chromosome DNA was not detected in lung tissue at 5 weeks in cell-treated groups.
TGF-␤, PDGF, and IGF mRNA expressions in lung tissue were higher, while VEGF expression was lower in E-SAL compared to C-SAL. BMDMC administration led to an increase in IGF and VEGF mRNA expressions, and a reduction in TGF-␤ and PDGF expressions (Fig. 7) .
Discussion
In the present murine model of pulmonary elatase-induced emphysema, early intravenous BMDMC therapy led to: (1) reduction in mean linear intercept, fraction area of alveolar collapse and hyperinflation; (2) reduction in the number of mononuclear cells and neutrophils and collagen fiber deposition in lung tissue; (3) increase in elastic fibers in the alveolar septa; (4) decrease in airway epithelium and alveolar-capillary membrane damage as well as elastic fiber breakdown; (5) reduction in the degree of lung apoptotic cells and caspase-3 expression, and (6) improvement of right ventricular wall thickness and right ventricular area followed by * Significantly different from C-SAL (p < 0.05). † Significantly different from E-SAL (p < 0.05). C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC (2 × 10 6 ) 3 h after the first instillation of saline or PPE.
Table 3
Semi-quantitative analysis of lung electron microscopy. Values are median (25th-75th percentile) of five mice in each group. Lung tissue score was assigned independently by two investigators. Pathologic findings were graded according to a 5-point semi-quantitative severity-based scoring system: 0 = normal lung parenchyma, 1 = changes in 1-25%, 2 = changes in 26-50%, 3 = changes in 51-75%, and 4 = changes in 76-100% of the examined structure. C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC (2 × 10 6 ) 3 h after the first instillation of saline or PPE. * Significantly different from C-SAL (p < 0.05). a reduction in collagen fibers in lung arterial vessels. Our findings suggest that the lung and heart may be protected by a mechanism linked to a balance between growth factors.
In the present study, emphysema was induced by multiple intratracheal instillations of porcine pancreatic elastase. This model, initially described in NMRI mice (Luthje et al., 2009 ), leads to lung, cardiovascular, and systemic impairment (Antunes and Rocco, 2011) , and induced lung and cardiovascular damage in our C57BL/6 mice. Moreover, this method of emphysema induction yields lengthy progressive inflammatory and remodeling processes, in addition to alveolar destruction.
The present study is the first to demonstrate the protective effects of early BMDMC administration to the lung and heart in experimental pulmonary elastase-induced emphysema. To identify this homing of bone marrow cells to the lung parenchyma, we used PCR of Y chromosome-specific sequences. However, Y chromosome DNA was not detected in lung tissue at day 28 in cell-treated groups, suggesting that the benefits we observed probably result from paracrine effects. In this context, a recent study showed that that bone marrow cell therapy improved smoke-induced emphysema through paracrine effects rather than stem cell engraftment, and reported that cell-free conditioned media of MSC (MSC-CM) also induced repair (Huh et al., 2011) .The injection of BMDMC even in normal lungs led to neutrophil increase in lung tissue, with no functional effects. This increment may be attributed to: presence of neutrophils in the pool of BMDMC and/or recruitment of these cells by chemoattractive stimuli (Araújo et al., 2010; Prota et al., 2010; Abreu et al., 2011a; Maron-Gutierrez et al., 2011) . Several studies have reported that circulating precursor cells are reduced (Bonsignore et al., 2006; Huertas et al., 2010) , and that VEGF-dependent precursor cell mobilization is impaired (Hattori et al., 2001) in human COPD. In this line, the administration of exogenous BMDMC in the current study might have contributed to the reduction of airway epithelial cell damage, tissue remodeling and inflammatory processes by increasing the available pool of circulating precursor cells. We demonstrated that early BMDMC administration led to less hyperinflation and collapsed areas as well as inflammatory cell infiltration in the lung parenchyma, reduced small airways collagen deposition, and elastic fiber preservation. This is in agreement with a recent report that mechanical forceinduced failure of the locally weakened collagen is correlated to structural changes in the lung undergoing heterogeneous consequences of elastase injury (Hamakawa et al., 2010) .
Ultrastructural analysis using electron microscopy revealed higher preservation of endothelial cells, type II pneumocyte and basement membrane, associated with reduction of collagen fiber deposition and elastic fiber breakdown. Besides, several typical features of regenerative processes, such as enlarged type II pneumocytes with augmented lamellar bodies, as well as the presence of multinucleated and undifferentiated cells in lung parenchyma were observed in the E-CELL group, suggesting that BMDMC may modulate elastase injury and play an important role in the repair of damaged areas. However, the exact mechanisms responsible for cell restoration remain unclear. It has been suggested that these multinucleated cells could be the result of a fusion between macrophages and BMDMCs, or between macrophages and injured epithelial cells (Krause, 2008) . Additionally, it has been described that macrophages behave in vitro as stem cell attractors. Once at the site of injury, the ability of precursor cells to reconstitute the damaged tissues depends on the signals generated in situ by the macrophages (Lolmede et al., 2009) .
Besides their proven plasticity, most beneficial effects of stem cells have been attributed to paracrine effects, that is, a capacity of modulating cytokines and growth factor synthesis without being present at the injury site (Abreu et al., 2011b; Doorn et al., 2011) . Paracrine effects have been demonstrated in several models of lung diseases, including emphysema (Shigemura et al., 2006; Zhen et al., 2010; Huh et al., 2011; Schweitzer et al., 2011) , and appear to be mediated by mainly VEGF, KGF, and cytokines (Zhen et al., 2010) . There is evidence that the impairment of this signaling pathway is intrinsically connected with the pathogenesis of emphysema, leading to epithelial and endothelial cell apoptosis and protease/antiprotease imbalance (Taraseviciene-Stewart and Voelkel, 2008; Huertas and Palange, 2011) . Similarly, in the present study, elastase induced apoptosis through high mRNA expression of the pro-apoptotic caspase-3. The protease also hampered the expression of VEGF, while BMDMC therapy yielded an increase in mRNA expression of VEGF. VEGF is known to stimulate endothelial and type II cell growth and survival by binding VEGF receptor 2 (Fehrenbach et al., 1999) , supporting a lower degree of apoptosis and ultrastructural regenerative process as observed in the E-CELL group. We demonstrated that BMDMCs were able to prevent the increase in PDGF and TGF-␤ mRNA expressions at day 28, which is in accordance with the reduced collagen fiber deposition observed in the E-CELL group, since inhibition of PDGF has been reported to prevent fibrosis (Abdollahi et al., 2005) . In this line, TGF-␤ is a potent inducer of collagen production by fibroblasts and myofibroblasts, whereas the most important effect of PDGF is as a mitogen for these cells, even though it also enhances collagen production (Hoyle et al., 1999; Morty et al., 2009 ). Conversely, BMDMCs yielded an increase in IGF expression, a growth factor associated with re-epithelization (Yamashita et al., 2005) and anti-apoptotic (Sadat et al., 2007) and angiogenic (Oskowitz et al., 2011) processes, suggesting that this may be the mechanism through which BMDMCs warrant the preservation of alveolar epithelial and endothelial cells. Regarding the absence of donated cells in receptor tissue, our results also point to a paracrine action of BMDMCs, reducing airway, lung parenchyma as well as pulmonary vessel wall damage. Additionally, our protocol of elastase-induced emphysema led to cardiovascular damage, which was attenuated by BMDMC therapy. In this line, echocardiographic measurements showed a reduction in wall thickness and area of right ventricle associated with a reduction in the amount of collagen and elastic fiber in pulmonary vessel wall after BMDMC administration. In this context, Yoshida and colleagues described similar improvement of pulmonary arterial hypertension through VEGF upregulation (Yoshida et al., 2009) . Pulmonary arterial hypertension induces morphological changes in right ventricle, a pathologic condition known as cor pulmonale. This disorder may occur as a result of various combined mechanisms, including loss of pulmonary vascular capacity due to parenchymal destruction (Liebow, 1959) , pulmonary arterial vasoconstriction due to hypoxemia and respiratory acidosis (Barbera et al., 2003) , fibrotic lung injury (Cottin et al., 2005) , pulmonary hyperinflation with elevated intrathoracic pressure (Jorgensen et al., 2007) , and atherosclerosis (Arunachalam et al., 2010) . All these factors promote progressive blood flow restriction to pulmonary vascular bed, leading to right ventricular hypertrophy. Huh and colleagues have reported that BMDMCs alleviate pulmonary hypertension in a cigarette smoke-induced emphysema model, inhibiting muscularization in small pulmonary vessels and stimulating VEGF-induced angiogenesis (Huh et al., 2011) . Similarly, in the current study, a right cardiac dysfunction was also detected in E-SAL, which was significantly minimized in the E-CELL group. This behavior was accompanied by a marked reduction in collagen fiber content in airways, pulmonary wall vessels, and alveolar septa, and associated with a lower mRNA expression of TGF-␤ and PDGF. Severe COPD leads to cor pulmonale combined with secondary reduction in left ventricular filling, stroke volume and cardiac output (Barr et al., 2010) . Nevertheless, no left ventricular dysfunction was found in our study, which implies that the present murine model of elastase-induced emphysema did not reach such high severity and/or did not have sufficient time to develop.
The present study has some limitations: (1) BMDMC were injected 3 h after first elastase administration. Consequently, more studies should be performed to analyze BMDMC effects after the injury is established; (2) all data were analyzed at 5 weeks. Therefore, the time course analysis following BMDMC therapy was not performed, limiting the understanding of the early effects of cell therapy; (3) Y chromosome DNA was also studied only at 5 weeks in cell-treated groups, and the behavior of BMDMC immediately after injection was not analyzed; (4) elastolysis was not evaluated using casein and elastin zymography but electron microscopy, and (5) we were not able to determine whether BMDMC had a direct beneficial effect on the heart or an indirect benefit mediated by improvement of lung injury. Therefore, future studies analyzing heart data, such as right ventricular weight, collagen fiber content, apoptosis, and cytokine/growth factor expressions will be required to better elucidate the direct effect of elastase or cell therapy on the heart.
In conclusion, in the present murine model of pulmonary elastase-induced emphysema, BMDMC therapy was effective to prevent lung and cardiovascular damage. These beneficial effects might be attributed to paracrine effects modulating the expression of growth factors involved in the pathogenesis of emphysema.
